Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491

Toxicology Letters

Volumn 227, Issue 2, 2014, Pages 75-83

  Wang, Xingxing ^a   Jiang, Fei ^a   Mu, Juan ^a   Ye, Xianqing ^a   Si, Lu ^a   Ning, Shilong ^a   Li, Zhong ^a   Li, Yuan ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Arsenic trioxide; Epithelial mesenchymal transition; Hepatocellular carcinoma; Matrix metalloproteinases; MicroRNA 491; Nuclear factor B

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 491; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DEMETHYLATION; ENZYME INACTIVATION; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MIGRATION INHIBITION; PRIORITY JOURNAL; TUMOR INVASION;

ARSENIC TRIOXIDE; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR CARCINOMA; MATRIX METALLOPROTEINASES; MICRORNA-491; NUCLEAR FACTOR ΚB;

ARSENICALS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NF-KAPPA B; OXIDES; SIGNAL TRANSDUCTION;

EID: 84899083034     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.03.016     Document Type: Article

References (43)

1. Bobe P., Chelbi-Alix M.K. New therapeutic perspectives for arsenic: from acute promyelocytic leukemia to autoimmune diseases. Med. Sci.: M/S 2008, 24:967-971.
2. Choi H.S., Yim S.H., Xu H.D., Jung S.H., Shin S.H., Hu H.J., Jung C.K., Choi J.Y., Chung Y.J. Tropomyosin3 overexpression and a potential link to epithelial-mesenchymal transition in human hepatocellular carcinoma. BMC Cancer 2010, 10:122.
3. Chow S.K., Chan J.Y., Fung K.P. Inhibition of cell proliferation and the action mechanisms of arsenic trioxide (As2O3) on human breast cancer cells. J. Cell. Biochem. 2004, 93:173-187.
4. Diepart C., Karroum O., Magat J., Feron O., Verrax J., Calderon P.B., Gregoire V., Leveque P., Stockis J., Dauguet N., Jordan B.F., Gallez B. Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors. Cancer Res. 2012, 72:482-490.
5. Ding S.J., Li Y., Shao X.X., Zhou H., Zeng R., Tang Z.Y., Xia Q.C. Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials. Proteomics 2004, 4:982-994.
6. Du J., Zhou N., Liu H., Jiang F., Wang Y., Hu C., Qi H., Zhong C., Wang X., Li Z. Arsenic induces functional re-expression of estrogen receptor alpha by demethylation of DNA in estrogen receptor-negative human breast cancer. PLoS One 2012, 7:e35957.
7. Farazi P.A., DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat. Rev. Cancer 2006, 6:674-687.
8. Fei M., Lu M., Wang Y., Zhao Y., He S., Gao S., Ke Q., Liu Y., Li P., Cui X., Shen A., Cheng C. Arsenic trioxide-induced growth arrest of human hepatocellular carcinoma cells involving FOXO3a expression and localization. Med. Oncol. (Northwood, London, England) 2009, 26:178-185.
9. Gabriely G., Wurdinger T., Kesari S., Esau C.C., Burchard J., Linsley P.S., Krichevsky A.M. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol. Cell. Biol. 2008, 28:5369-5380.
10. Ghavamzadeh A., Alimoghaddam K., Ghaffari S.H., Rostami S., Jahani M., Hosseini R., Mossavi A., Baybordi E., Khodabadeh A., Iravani M., Bahar B., Mortazavi Y., Totonchi M., Aghdami N. Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy. Ann. Oncol. 2006, 17:131-134.
11. Han Y.P., Tuan T.L., Wu H., Hughes M., Garner W.L. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J. Cell Sci. 2001, 114:131-139.
12. Hao H., Liu J., Liu G., Guan D., Yang Y., Zhang X., Cao X., Liu Q. Depletion of GRIM-19 accelerates hepatocellular carcinoma invasion via inducing EMT and loss of contact inhibition. J. Cell. Physiol. 2012, 227:1212-1219.
13. Huang W.C., Chan S.H., Jang T.H., Chang J.W., Ko Y.C., Yen T.C., Chiang S.L., Chiang W.F., Shieh T.Y., Liao C.T., Juang J.L., Wang H.C., Cheng A.J., Lu Y.C., Wang L.H. miRNA-491-5p and GIT1 Serve as Modulators and Biomarkers for oral squamous cell carcinoma invasion and metastasis. Cancer Res. 2014, 74:751-764.
14. Jiang R., Li Y., Xu Y., Zhou Y., Pang Y., Shen L., Zhao Y., Zhang J., Zhou J., Wang X., Liu Q. EMT and CSC-like properties mediated by the IKKbeta/IkappaBalpha/RelA signal pathway via the transcriptional regulator, snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes. Arch. Toxicol. 2013, 87:991-1000.
15. Kavitha K., Kowshik J., Kishore T.K., Baba A.B., Nagini S. Astaxanthin inhibits NF-(B and Wnt/β-catenin signaling pathways via inactivation of ERK/MAPK and PI3K/AKT to induce intrinsic apoptosis in a hamster model of oral cancer. Biochim. Biophys. Acta 2013, 1830:4433-4444.
16. Kim J.H., Na H.K., Pak Y.K., Lee Y.S., Lee S.J., Moon A., Surh Y.J. Roles of ERK and p38 mitogen-activated protein kinases in phorbol ester-induced NF-kappaB activation and COX-2 expression in human breast epithelial cells. Chem. Biol. Interact. 2008, 171:133-141.
17. Kogan S.C. Medicine. Poisonous Contacts 2010, 328:184-185. Science, New York, NY.
18. Lee T.K., Poon R.T., Yuen A.P., Ling M.T., Kwok W.K., Wang X.H., Wong Y.C., Guan X.Y., Man K., Chau K.L., Fan S.T. Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 2006, 12:5369-5376. (An official journal of the American Association for Cancer Research).
19. Li Y., Jiang R., Zhao Y., Xu Y., Ling M., Pang Y., Shen L., Zhou Y., Zhang J., Zhou J., Wang X., Liu Q. Opposed arsenite-mediated regulation of p53-survivin is involved in neoplastic transformation, DNA damage, or apoptosis in human keratinocytes. Toxicology 2012, 300:121-131.
20. Li Y., Tang Z.Y., Ye S.L., Liu Y.K., Chen J., Xue Q., Chen J., Gao D.M., Bao W.H. Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J. Gastroenterol. 2001, 7:630-636.
21. Liu Z.M., Tseng J.T., Hong D.Y., Huang H.S. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells. Biochem. J. 2011, 438:349-358.
22. Miller W.H., Schipper H.M., Lee J.S., Singer J., Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 2002, 62:3893-3903.
23. Oketani M., Kohara K., Tuvdendorj D., Ishitsuka K., Komorizono Y., Ishibashi K., Arima T. Inhibition by arsenic trioxide of human hepatoma cell growth. Cancer Lett. 2002, 183:147-153.
24. 3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. J. Cell. Biochem. 2005, 95:955-969.
25. Peng H., Dara L., Li T.W., Zheng Y., Yang H., Tomasi M.L., Tomasi I., Giordano P., Mato J.M., Lu S.C. MAT2B-GIT1 interplay activates MEK1/ERK 1 and 2 to induce growth in human liver and colon cancer. Hepatology 2013, 57:2299-2313.
26. 3) in acute promyelocytic leukemia. Int. J. Hematol. 2013, 97:717-725.
27. Tsochatzis E.A., Meyer T., Burroughs A.K. Hepatocellular carcinoma. N. Engl. J. Med. 2012, 366(92):92-93. author reply.
28. Uchino K., Tateishi R., Shiina S., Kanda M., Masuzaki R., Kondo Y., Goto T., Omata M., Yoshida H., Koike K. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 2011, 117:4475-4483.
29. Wu C.W., Ng S.S., Dong Y.J., Ng S.C., Leung W.W., Lee C.W., Wong Y.N., Chan F.K., Yu J., Sung J.J. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012, 61:739-745.
30. Xiang Z.L., Zeng Z.C., Fan J., Tang Z.Y., Zeng H.Y., Gao D.M. Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1alpha VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin. Cancer Res. 2011, 17:5463-5472. (An official journal of the American Association for Cancer Research).
31. Xu J., Zhu X., Wu L., Yang R., Yang Z., Wang Q., Wu F. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/beta-catenin pathway. Liver Int. 2012, 32:752-760. (Official journal of the International Association for the Study of the Liver).
32. Yan W., Zhang W., Sun L., Liu Y., You G., Wang Y., Kang C., You Y., Jiang T. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme. Brain Res. 2011, 1411:108-115.
33. Yang P., Yuan W., He J., Wang J., Yu L., Jin X., Hu Y., Liao M., Chen Z., Zhang Y. Overexpression of EphA2 MMP-9, and MVD-CD34 in hepatocellular carcinoma: implications for tumor progression and prognosis. Hepatol. Res. 2009, 39:1169-1177. (The official journal of the Japan Society of Hepatology).
34. Yang Y., Li Y., Wang K., Wang Y., Yin W., Li L. P38/NF-kappaB/snail pathway is involved in caffeic acid-induced inhibition of cancer stem cells-like properties and migratory capacity in malignant human keratinocyte. PLoS One 2013, 8:e58915.
35. Yin G., Haendeler J., Yan C., Berk B.C. GIT1 functions as a scaffold for MEK1-extracellular signal-regulated kinase 1 and 2 activation by angiotensin II and epidermal growth factor. Mol. Cell. Biol. 2004, 24:875-885.
36. Yoon S., Kim T.H., Natarajan A., Wang S.S., Choi J., Wu J., Zern M.A., Venugopal S.K. Acute liver injury upregulates microRNA-491-5p in mice and its overexpression sensitizes Hep G2 cells for tumour necrosis factor-alpha-induced apoptosis. Liver Int. 2010, 30:376-387. (Official journal of the International Association for the Study of the Liver).
37. 3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo. Gynecol. Oncol. 2007, 106:400-406.
38. Zhang N., Cai W., Yin G., Nagel D.J., Berk B.C. GIT1 is a novel MEK1-ERK1/2 scaffold that localizes to focal adhesions. Cell Biol. Int. 2009, 34:41-47.
39. Zhang K., Zhaos J., Liu X., Yan B., Chen D., Gao Y., Hu X., Liu S., Zhang D., Zhou C. Activation of NF-B upregulates snail and consequent repression of E-cadherin in cholangiocarcinoma cell invasion. Hepato-Gastroenterology 2011, 58:1-7.
40. Zhang X., Jia S., Yang S., Yang Y., Yang T., Yang Y. Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression. J. Cell. Biochem. 2012, 113:3528-3535.
41. Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B., Liang W.X., Song A.X., Lallemand-Breitenbach V., Jeanne M., Zhang Q.Y., Yang H.Y., Huang Q.H., Zhou G.B., Tong J.H., Zhang Y., Wu J.H., Hu H.Y., de The H., Chen S.J., Chen Z. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Science (New York, NY) 2010, 328:240-243.
42. Zhou Y., Li Y., Ye J., Jiang R., Yan H., Yang X., Liu Q., Zhang J. MicroRNA-491 is involved in metastasis of hepatocellular carcinoma by inhibitions of matrix metalloproteinase and epithelial to mesenchymal transition. Liver Int. 2013, 33:1271-1280. (Official journal of the International Association for the Study of the Liver).
43. Zhu K., Dai Z., Pan Q., Wang Z., Yang G.H., Yu L., Ding Z.B., Shi G.M., Ke A.W., Yang X.R., Tao Z.H., Zhao Y.M., Qin Y., Zeng H.Y., Tang Z.Y., Fan J., Zhou J. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin. Cancer Res. 2011, 17:7294-7302. (An official journal of the American Association for Cancer Research).